ANVS
Annovis Bio Inc
1.20$
-7.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +485.3% | -94.7% | – | – | – | -89.2% | – | – | – | – | – | |
| – | – | – | – | +70.6% | -89.7% | +21,884.1% | +151.9% | +94.8% | -49.4% | -17.1% | -53.1% | |
| – | -664.3% | – | -99.4% | +70.6% | +6.4% | +2,049.7% | +148.4% | – | – | – | – | |
| – | – | – | – | -24.7% | +481.1% | -195.1% | – | -273.0% | – | – | +131.6% | |
| – | -48.9% | +0.0% | -100.0% | – | – | – | -100.0% | – | +0.0% | +0.0% | -100.0% | |
| – | -92.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | +0.0% | +25,695.2% | -25.9% | – | – | +288.1% | – | – | – | – | |
| – | – | +0.0% | +200.4% | +0.0% | +0.0% | – | – | – | – | – | – | |
| – | -97.3% | +0.0% | +87.1% | -25.9% | +79.8% | +2,618.1% | +288.1% | -100.0% | +375,888.1% | +53.9% | +29.6% | |
| – | -169.2% | – | – | – | – | – | +365.9% | -146.0% | – | – | +87.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.